Observational Study
Copyright ©The Author(s) 2025.
World J Diabetes. Aug 15, 2025; 16(8): 106967
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.106967
Table 1 Characteristics of participants.
Characteristic
GDM
T2DM
P value
N89 (58.6%)63 (41.4%)-
Age (years)35.3 ± 3.835.6 ± 3.90.717
Age at diagnosis (years)35 (33-38)33 (29.5-36)0.002
Gestational age at first visit (weeks)29.3 (26.6-32.7)10.7 (8.1-16.7)< 0.001
Pre-pregnancy BMI (kg/m2)23.3 (20.4-25.8)25.1 (22.1-29.0)0.003
Gravidity2 (1-3)1 (1-2)0.04
Parity0 (0-1)0 (0-0)0.072
Mode of conception
Natural conception68 (76.4%)53 (84.1%)0.495
IVF-ET16 (18.0%)8 (12.7%)0.488
Ovulation induction by letrozole5 (5.6%)2 (3.2%)0.516
Singleton pregnancy83 (93.3%)62 (98.4%)0.24
Multiple pregnancy6 (6.7%)1 (1.6%)0.24
HbA1c (%)5.2 (5.0-5.5)5.3 (5.0-5.9)0.02
GA (%)13.3 (12.2-13.7)13.3 (12.6-14.6)0.364
Hemoglobin (g/L)125.7 ± 10.1124.9 ± 10.80.613
Serum iron (μg/dL)92.0 (75.5-116.0)108.0 (82-132)0.049
Serum ferritin (ng/mL)28.5 (16.0-52.8)53 (35-92)< 0.001
Serum vitamin B12 (pg/mL)312 (228-433)342 (281-476)0.072
Pharmacotherapy
Insulin50 (56.2%)40 (63.5%)0.012
Metformin0 (0%)1 (1.6%)0.349
Insulin and metformin0 (0%)8 (12.7%)< 0.001
CGM profiles2 (1-3)2 (1-6)0.063
CGM metrics
Number of days CGM worn (days)112.5 (11.3-12.8)12.9 (11.3-12.9)0.081
Percentage of time CGM is active (%)100 (100-100)100 (100-100)0.636
Mean glucose (mmol/L)5.5 (5.2-5.8)5.4 (5.0-5.9)0.214
Time in range (%) (3.5-7.8 mmol/L)93.4 (87.5-96.8)91.1 (84.7-95.4)0.001
Time above range (%) (> 7.8 mmol/L)3.9 (1.3-8.6)4.8 (1.6-10.7)0.045
Time below range (%) (< 3.5 mmol/L)0.7 (0.2-3.1)1.4 (0.2-4.3)0.021
Time below range (%) (< 3.0 mmol/L)0.1 (0-0.9)0.2 (0-1.1)0.215
Coefficient of variation (%)19.9 (17.5-23.1)21.9 (19.0-25.5)< 0.001
Table 2 Mixed-effects models predicting the relationship between mean glucose and hemoglobin A1c in pregnant participants with gestational diabetes mellitus and type 2 diabetes mellitus.
Model
AIC
Fixed effects
Intercept (95%CI)
P value
HbA1c
P value
Other covariates
P value
11019.85Intercept only5.548 (5.412-5.683)< 0.001----
2901.65HbA1c1.957 (1.345-2.569)< 0.0010.669 (0.557-0.782)< 0.001--
3895.41HbA1c1.619 (0.962-2.277)< 0.0010.685 (0.573-0.798)< 0.001--
Gestational age10.010 (0.003-0.017)0.004
4899.29HbA1c1.529 (0.800-2.259)< 0.0010.639 (0.524-0.754)< 0.001--
Prepregnancy BMI0.024 (0.002-0.047)0.036
5689.21HbA1c1.956 (1.094-2.818)< 0.0010.715 (0.597-0.834)< 0.001--
Hemoglobin-0.002 (-0.007 to 0.004)0.492
6889.26HbA1c2.093 (1.417-2.770)< 0.0010.665 (0.552-0.778)< 0.001--
Serum iron-0.001 (-0.003 to 0.001)0.349
7676.89HbA1c1.165 (0.095-2.235)0.0330.692 (0.568-0.816)< 0.001--
Gestational age0.010 (0.002-0.017)0.010
Prepregnancy BMI0.029 (0.005-0.054)0.018
Hemoglobin-0.002 (-0.008 to 0.003)0.371
Serum iron0.000 (-0.002 to 0.003)0.876
Table 3 Mixed-effects models predicting the relationship between mean glucose and glycated albumin in pregnant participants with gestational diabetes mellitus and type 2 diabetes mellitus.
Model
AIC
Fixed effects
Intercept (95%CI)
P value
GA
P value
Other covariates
P value
11019.85Intercept only5.548 (5.412-5.683)< 0.001----
2937.08GA2.518 (1.853-3.184)< 0.0010.234 (0.183-0.284)< 0.001--
3933.63GA2.273 (1.579-2.968)< 0.0010.237 (0.187-0.288)< 0.001--
Gestational age10.008 (0.001-0.015)0.019
4908.75GA0.523 (-0.393 to 1.438)0.2630.253 (0.205-0.302)< 0.001--
Prepregnancy BMI0.072 (0.047-0.096)< 0.001
5747.13GA2.169 (1.143-3.195)< 0.0010.232 (0.174-0.289)< 0.001--
Hemoglobin0.003 (-0.002 to 0.009)0.269
6914.80GA2.777 (2.076-3.478)< 0.0010.242 (0.191-0.293)< 0.001--
Serum iron-0.003 (-0.006 to -0.001)0.015
7701.73GA0.160 (-1.441 to 1.212)0.8070.270 (0.215-0.325)< 0.001--
Gestational age0.010 (0.001-0.016)0.021
Prepregnancy BMI0.076 (0.050-0.102)< 0.001
Hemoglobin0.002 (-0.003 to 0.008)0.373
Serum iron-0.001 (-0.004 to 0.001)0.242